BeStock  
Stocks › Biotechnology › SANA

Sana Biotechnology SANA

US equityMarket cap rank #3609Biotechnology
$1.59 −$0.15 (-8.62%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $1.64 +3.06%
Open$1.70
Prev close$1.74
Day range$1.57 – $1.75
Volume4.46M
Market cap$476.42M
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$0.00
Operating profit$18.51M+142.5% YoY
Net profit$20.40M+148.4% YoY
Diluted EPS$0.07+143.8% YoY
Free cash flow-$39.54M-34.2% YoY
Operating cash flow-$38.75M

Revenue, last 8 quarters

$0.0Dec '24$0.0Mar '25$0.0Jun '25$0.0Sep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26$0.0Sep '26

Net profit, last 8 quarters

$-49.1MDec '24$-49.4MMar '25$-93.8MJun '25$-42.2MSep '25$-58.8MDec '25$-47.2MMar '26$-63.6MJun '26$20.4MSep '26

Diluted EPS by quarter

-0.21Dec '24-0.21Mar '25-0.39Jun '25-0.16Sep '25-0.21Dec '25-0.17Mar '26-0.22Jun '260.07Sep '26

Free cash flow by quarter

$-47.6MDec '24$-48.8MMar '25$-33.0MJun '25$-29.5MSep '25$-33.5MDec '25$-37.7MMar '26$-34.4MJun '26$-39.5MSep '26

Annual revenue

$0.0FY20$0.0FY21$0.0FY22$0.0FY23$0.0FY24$0.0FY25

Profitability & balance sheet

Return on equity-79.5%
Return on assets-36.8%
Return on invested capital-60.1%
Current ratio1.77
Liabilities / assets52.0%
Cash & investments$121.73M
Total debt$40.52M
Net cash (debt)$81.20M

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expense -$18.51M $65.42M $48.61M $205.71M $61.20M
Selling and Admin Expenses $10.94M $10.78M $11.46M $44.30M $12.19M
-General & Admin Expense $10.94M $10.78M $11.46M $44.30M $12.19M
Research & Development -$29.45M $54.64M $37.15M $161.41M $49.01M
Operating Profit $18.51M -$65.42M -$48.61M -$205.71M -$61.20M
Net Non-Operating Interest Income (Expense) $1.22M $1.13M $951,000.00 $3.85M $1.28M
Non-Operating Interest Income $1.22M $1.13M $951,000.00 $3.85M $1.28M
Other Income (Expense) $676,000.00 $656,000.00 $453,000.00 -$42.31M $1.10M
Special Income (Charges) $0.00 $0.00 – -$44.61M $0.00
-Less:Impairment of Capital Assets $0.00 $0.00 – $44.61M $0.00
Other Non-Operating Income (Expenses) $676,000.00 $656,000.00 $453,000.00 $2.31M $1.10M
Pretax Profit $20.40M -$63.64M -$47.21M -$244.17M -$58.83M
Net Profit $20.40M -$63.64M -$47.21M -$244.17M -$58.83M
Profit from Continuing Operations $20.40M -$63.64M -$47.21M -$244.17M -$58.83M
Net Income to Parent Company $20.40M -$63.64M -$47.21M -$244.17M -$58.83M
Net Income to Common Stockholders $20.40M -$63.64M -$47.21M -$244.17M -$58.83M
Basic EPS $0.07 -$0.22 -$0.17 -$0.96 -$0.21
Diluted EPS $0.07 -$0.22 -$0.17 -$0.96 -$0.21

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $376.13M $431.52M $373.59M $416.89M $416.89M
Total Current Assets $132.31M $170.63M $111.69M $148.68M $148.68M
Cash and Cash Equivalents & Short-Term Investments $121.73M $160.49M $101.14M $138.38M $138.38M
-Cash and Cash Equivalents $41.10M $57.07M $83.80M $71.87M $71.87M
-Short Term Investments $80.62M $103.42M $17.34M $66.51M $66.51M
Restricted Cash $3.76M $4.20M $4.20M $4.20M $4.20M
Other Current Assets $6.82M $5.94M $6.36M $6.10M $6.10M
Total Non-Current Assets $243.82M $260.89M $261.90M $268.21M $268.21M
Net PPE $43.44M $60.52M $61.52M $65.22M $65.22M
-Gross PPE $105.47M $119.90M $118.66M $119.97M $119.97M
-Accumulated Depreciation -$62.03M -$59.38M -$57.15M -$54.76M -$54.76M
Goodwill and Other Intangible Assets $199.82M $199.82M $199.82M $199.82M $199.82M
-Goodwill $140.63M $140.63M $140.63M $140.63M $140.63M
-Other Intangible Assets $59.20M $59.20M $59.20M $59.20M $59.20M
Other Non-Current Assets $551,000.00 $552,000.00 $563,000.00 $3.17M $3.17M
Total Liabilities $195.76M $276.95M $254.35M $256.01M $256.01M
Total Current Liabilities $74.88M $123.75M $86.27M $78.73M $78.73M
Payables $1.95M $1.36M $2.12M $1.67M $1.67M
-Accounts Payable $1.95M $1.36M $2.12M $1.67M $1.67M
Current Accrued Expenses $9.70M $9.67M $10.32M $10.19M $10.19M
Short-Term Debt and Capital Lease Obligation $13.32M $14.51M $14.88M $14.94M $14.94M
-Current Capital Lease Obligation $13.32M $14.51M $14.88M $14.94M $14.94M
Other Current Liabilities $40.65M $90.81M $53.56M $40.20M $40.20M
Total Non-Current Liabilities $120.88M $153.20M $168.09M $177.28M $177.28M
Long Term Debt and Capital Lease Obligation $40.52M $59.23M $60.45M $63.92M $63.92M
-Long Term Capital Lease Obligation $40.52M $59.23M $60.45M $63.92M $63.92M
Other Non-Current Liabilities $80.36M $93.97M $107.64M $113.36M $113.36M
Total Equity $180.36M $154.57M $119.24M $160.88M $160.88M
Stockholders' Equity $180.36M $154.57M $119.24M $160.88M $160.88M
Capital Stock $30,000.00 $30,000.00 $27,000.00 $27,000.00 $27,000.00
-Common Stock $30,000.00 $30,000.00 $27,000.00 $27,000.00 $27,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $2.12B $2.11B $2.02B $2.01B $2.01B
Retained Earnings -$1.94B -$1.96B -$1.90B -$1.85B -$1.85B
Gains/Losses Not Affecting Retained Earnings -$104,000.00 -$66,000.00 -$2,000.00 $28,000.00 $28,000.00

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$38.75M -$32.79M -$37.38M -$143.83M -$32.64M
Net cash flow from continuing operations -$38.75M -$32.79M -$37.38M -$143.83M -$32.64M
Net Income from Continuing Operations $20.40M -$63.64M -$47.21M -$244.17M -$58.83M
Depreciation & Depletion & Amortization $2.97M $2.23M $2.39M $12.75M $3.05M
Other Non-Cash Items -$61.19M $22.15M $8.29M $27.63M $13.38M
Change in Working Capital -$6.26M $1.12M -$6.51M -$10.11M $3.41M
-Change in Prepaid Assets -$805,000.00 $295,000.00 $1.63M $1.17M -$696,000.00
-Change in Payables and Accrued Expense $1.94M $271,000.00 -$6.64M -$8.28M $5.57M
-Change In Other Working Capital -$7.40M $556,000.00 -$1.50M -$3.00M -$1.46M
Net cash flow from investing $22.35M -$87.52M $49.44M -$40.24M -$16.50M
Net Cash Flow from Continuing Investing Activities $22.35M -$87.52M $49.44M -$40.24M -$16.50M
Net PPE Purchase and Sale -$791,000.00 -$1.62M -$288,000.00 -$938,000.00 -$873,000.00
Net Investment Purchase and Sale $23.10M -$85.92M $49.48M -$40.73M -$16.28M
Net Other Investing Changes $45,000.00 $23,000.00 $248,000.00 $1.43M $661,000.00
Financing Cash Flow $0.00 $93.58M -$128,000.00 $128.73M $17.65M
Net Cash Flow from Continuing Financing Activities $0.00 $93.58M -$128,000.00 $128.73M $17.65M
Net Common Stock Issuance -$24,000.00 – – – –
Proceeds from Stock Option Exercised $117,000.00 $245,000.00 $59,000.00 $2.68M $1.06M
Net Other Financing Charges -$93,000.00 -$88,000.00 -$96,000.00 – –
Ending Cash Balance $44.87M $61.27M $88.00M $76.07M $76.07M
Net Change in Cash -$16.40M -$26.73M $11.93M -$55.33M -$31.49M
Beginning Cash Balance $61.27M $88.00M $76.07M $131.40M $107.55M
Free Cash Flow -$39.54M -$34.41M -$37.67M -$144.77M -$33.51M
Net Issuance Payments Of Debt – – -$91,000.00 $126.06M –

Discussion

No comments yet — be the first to weigh in on SANA.

Sign in to join the discussion.

Scroll to Top